Skip to main content
新芝生物 logo

新芝生物 — Investor Relations & Filings

Ticker · 920685 Beijing Stock Exchange Manufacturing
Open in API
Filings indexed 390 across all filing types
Latest filing 2023-03-23 Regulatory Filings
Country CN China
Listing Beijing Stock Exchange 920685

About 新芝生物

https://www.scientz.com/

Scientz Biotechnology specializes in the design and manufacture of high-performance life science instruments and laboratory equipment. The product range features ultrasonic cell disruptors, freeze dryers, gene guns, and high-pressure homogenizers, which are essential for sample preparation, cell lysis, and genetic engineering. The company also provides specialized solutions for tissue grinding, ultrasonic cleaning, and precise temperature control. These instruments serve a broad spectrum of applications in molecular biology, pharmaceutical research, environmental science, and agricultural technology. By integrating advanced ultrasonic and cryogenic technologies, Scientz supports research institutions and industrial laboratories in achieving accurate and reproducible results across various scientific disciplines.

Recent filings

Filing Released Lang Actions
中信证券股份有限公司关于宁波新芝生物科技股份有限公司使用募集资金置换已预先投入募投项目及已支付发行费用自筹资金的核查意见
Regulatory Filings
2023-03-23 Chinese
关于召开2023年第一次临时股东大会通知公告
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a notice announcing the convening of the 2023 first extraordinary general meeting of shareholders (临时股东大会) for Ningbo Scientz Biotechnology Co., Ltd. It details the meeting date, voting methods, agenda items to be discussed, registration methods, and other procedural information. There is no financial data, earnings, or report content included. The document is an announcement about a shareholders meeting, not a report or transcript. It fits the category of a Proxy Solicitation & Information Statement (PSI), which includes materials sent to shareholders to provide information and request votes for meetings. The document length is 2530 characters, which is relatively short and consistent with a meeting notice rather than a full report.
2023-03-23 Chinese
信息披露管理制度
Governance Information Classification · 95% confidence The document is a detailed information disclosure management system of a company, outlining the rules, responsibilities, and procedures for information disclosure, including periodic reports (quarterly, interim, annual), temporary reports, major event disclosures, insider trading restrictions, and internal controls. It references regulatory bodies such as the China Securities Regulatory Commission and the Beijing Stock Exchange, and covers compliance with laws and listing rules. The document is a governance and procedural manual rather than an actual financial report or announcement. It does not contain financial statements, earnings data, or voting results. It is not a report publication announcement or a certification. Therefore, it fits best under Governance Information (CGR), which covers reports detailing the company's internal rules, board structure, and governance practices.
2023-03-23 Chinese
第八届董事会第二次会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of the resolutions passed at the company's eighth board of directors' second meeting. It details the meeting's time, place, attendance, and the voting results on various proposals. The content focuses on board decisions and approvals, including financial management and procedural matters. There is no detailed financial data or comprehensive report content, but rather a summary of board meeting outcomes. This fits the category of Board/Management Information (MANG), which covers announcements of changes or decisions by the board of directors or senior management. The document length is short (2023 characters), and it is not an announcement of a report publication but a direct disclosure of board resolutions.
2023-03-23 Chinese
独立董事关于第八届董事会第二次会议相关事项的独立意见
Board/Management Information Classification · 95% confidence The document is an independent director's opinion on matters discussed at the company's eighth board meeting, specifically regarding the use of idle funds to purchase financial products and the use of raised funds to replace self-raised funds for investment projects. It includes legal references and confirms compliance with laws and company regulations. The document is a formal announcement related to board meeting decisions but does not contain financial statements or detailed financial data. It is not a full annual or interim report, nor an earnings release. It is not a proxy solicitation or voting result announcement. The content fits best under Board/Management Information (MANG) as it relates to board meeting matters and independent director opinions on company decisions.
2023-03-23 Chinese
第八届监事会第二次会议决议公告
Regulatory Filings Classification · 95% confidence The document is a resolution announcement from the Supervisory Board (监事会) of Ningbo New Zhisheng Biotechnology Co., Ltd. It details the convening and attendance of the meeting, the agenda items discussed, and the voting results on specific proposals related to the use of idle funds and fundraising capital. The document is short (1127 characters) and primarily serves as an official announcement of meeting resolutions rather than a detailed report or financial statement. It does not contain financial data, audit information, or detailed management discussion. It is not a report publication announcement since it contains substantive content about the meeting decisions. The content fits best under Regulatory Filings (RNS) as a general regulatory announcement about board resolutions and decisions that do not fit other specific categories.
2023-03-23 Chinese

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.